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lymphoma presenting in human
immunodeficiency virus-negative but Epstein-Barr
virus-positive patient: A case report
Li Ying Zhang1, Hui Yun Lin1, Lan Xiang Gao1*, Lin Li1, Yu Wang Tian1, Zhi Qin Liu2, Xiao Hua Shi3
and Zhi Yong Liang3Abstract: We report a 32-year-old Outer Mongolian man, with plasmablastic lymphoma (PBL) primarily occured in
the central nervous system and diagnosed by surgical resection. This patient appeared headache and Magnetic
resonance imaging (MRI) showed multiple lesions in the right cerebral hemisphere including the right frontal-
parietal lobe and right basal ganglia and the left cerebellum, he was diagnosed as lymphoma by stereotactic
biopsy in January 2009 in local hospital, and was given radiotherapy 33 times after the biopsy. The patient was
admitted to The Military General Hospital of Beijing PLA., Beijing, P.R. China on March 9th, 2011, with chief
complaints of right limbs convulsioned suddenly, then fell down and lose of his consciousness, then awoke after 4
to 5 minutes, with symptoms of angulus oris numbness and the right upper limb powerless ten days ago.
MRI of the brain revealed a well-defined hyperdense and enhancing mass in the left frontal-parietal lobe, the
meninges are closely related, there was extensive peritumoural edema noted with pressure effects, as evident by
effacement of the left lateral ventricles and a 0.5 cm shift of the midline to the right side.
Surgical resection showed markedly atypical, large singly dispersed or cohesive proliferation of plasmacytoid cells
with frequent abnormal mitoses and binucleation, some neoplastic cells were large with round or oval nuclei and
showed coarse chromatin and smaller or unapparent nucleoli, some neoplastic cells with prominent nucleoli,
apoptosis and necrosis were often presented. Immunohistochemistry staining and gene rearrangement together
with other supportive investigation confirmed the diagnosis of primary central nervous system plasmablastic
lymphoma. A month later, he was started on chemotherapy with R-CHOP (rituximab, cyclophosphamide,
doxorubicin, leurocristime and prednisone) for a week. Other supportive treatment was provided for symptomatic
epilepsy. The patient regained muscle strength in both upper limbs and right lower limb and the symptomatic
epilepsy was controlled after two weeks. Then the patient was discharged. Follow-up data shows the patient to be
alive eleven months after discharge.
Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/1649317674697046.
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Unlike the numerous subtypes of extra-central nervous
system (CNS) lymphoma, most primary central nervous
system lymphomas (PCNSLs) are a high-grade non-
Hodgkin’s subtype with the features of diffuse large B
cell lymphoma (DLBCL). So far there were two cases of
primary central neurous system PBL reports in the
world. One case occurred in the right basal ganglian [1],
another occurred in the left anterior frontal lobe [2]and
both patients were HIV-positive. Here we report a HIV-
negative but EBV-positive patient with a primary CNS
plasmablastic lymphoma, a rare variant of DLBCL.Figure 1 MR imaging of the head in 2009. (1) The MRI T1
Weighted Imaging shows that there are multiple masses with high
signals in the margin and low signals in the center, and T2
Weighted Imaging shows equal signals, in the right cerebral
hemisphere, especially in the right frontal-parietal lobe and the basal
ganglia area, and edema with low signals could be seen around the
mass. (2) The left cerebellum is also visible of abnormal signals.Case presentation
A 32-year-old Outer Mongolian man, who is a freelancer,
was born and grew up in the city of Ulan Bator, Capital of
Outer Mongolia. Ten days ago his right limbs convulsioned
suddenly, then he fell down and lose of consciousness, and
awoke after 4 to 5 minutes, with symptoms of angulus oris
numbness and the right upper limb powerless. He was re-
ferred to The Military General Hospital of Beijing PLA.,
Beijing, P.R. China on March 9th, 2011.
The patient accepted a eye operation because of acute
glaucoma in 2008, he denied any infection and family
histories such as HIV, HBV, HCV, HPV, Syphilis infec-
tions, cancer or hereditary diseases or organ transplant-
ation history. He never knew the infection of EBV before
this admission. He had no bad habits such as smoking
and alcoholism, no dust, toxins, radioactive material ex-
posure history, had never been to infectious disease
areas, had no habit of eating raw fish and raw meat, etc.
Two years prior to this hospital admission, this patient
began no incentive headache in January 2009, the headache
progressively serious, with some symptoms such as hiccups,
nausea, vomiting, urgent urination, dry stool, and the left
limb weakness which resulting in unsteady gait. MRI in-
spection in local hospital showed multiple lesions in the
right hemisphere, especially in the right frontal-parietal lobe
and basal ganglia and the left cerebellum areas (Figure 1, 2).
The patients carried the imaging films on his admission
which were done in local hospital. He dictated that he was
dignosed as lymphoma with biopsy in local hospital, but
the inspection of the neoplastic tissues was too small to
make a final and exact diagonosis, he was given radiother-
apy 33 times after the operation, the exact radiation regi-
mens and doses were whole skull (DT39.6 Gy/22f) and left
cerebellum (DT19.8 Gy/11f), with slight side effects such as
hair loss and sometimes uausea during the radiotherapy.
He felt intermittent headache but never carry out any
examination and treatment before this time admission.
On admission, the patient was with no fever, papilloe-
dema, but some neurological deficits including the myo-
dynamia of the proximal end of right upper limb wasstage IV, distal end of the right upper limb was stage III,
the myodynamia of the right lower limb was stage IV,
and Babinski syndrome (+), etc. noted on physical exam-
ination. Physical inspection revealed no enlargement of
general superficial lymph nodes and no mass was found
in the head and neck region, including the oral cavity.
Blood inspection showed that WBC 7.63x109/L, neu-
trophils 80.9%, RBC 4.6x1012/L, hemoglobin 139.0 g/L,
PLT 234x109/L; Biochemical inspection showed that
ALT 17 U/L, TBIL 9.60umol/L, DBIL 4.1 umol/L, TP
60.3 g/L, ALB 46.2 g/L, GLU 6.4 mmol/L, BUN
5.90 mmol/L, Cr 67.0 umol/L, all these indexes were
within the normal range. He was detected with no HIV,
HBsAg, HBcAg, HPV, Syphilis infection after this
admission.
MRI of the head revealed a well-defined hyperdense
and enhancing mass, measuring 3.6 cm × 3.0 cm ×
1.5 cm, in the left frontal-parietal lobe (Figure 2 1, 2).
The lateral border of the mass was closely related to the
meninges. There was extensive peritumoural edema
noted with pressure effects, as evident by effacement of
the left lateral ventricles and a 0.5 cm shift of the mid-
line to the right side. PET/CT revealed no enlargement
of deep lymph nodes and no mass in the head and neck
region, including the oral cavity, and in other regions of
the peripheral nervous system or organs.
Haematoxylin & eosin stain showed markedly atypical,
large singly dispersed or cohesive proliferation of plasma-
cytoid cells with frequent abnormal mitoses and binu-
cleation, some neoplastic cells were large with round or
oval nuclei and showed coarse chromatin and smaller or
unapparent nucleoli, some neoplastic cells with promin-
ent nucleoli, apoptosis and necrosis were often presented
(Figures 2 3, 4), no brain tissue was found in the
Table 1 Details of the results of immunohistochemistry
staining in tumor cells
Antibody Result Antibody Result
LCA Diffusely cell membrane positive CD4 Negative
CD38 Diffusely cell membrane positive CD5 Negative
CD79a Diffusely cell membrane positive CD7 Negative
Mum-1 Partly nuclei positive CD8 Negative
Kappa light
chain
Partly cytoplasm positive CD56 Negative
Lambda light
chain
Partly cytoplasm positive CD30 Negative
CD20 Partly cell membrane positive CD138 Negative
Plasma cell
marker
Partly cytoplasm positive ALK Negative
Ki-67 Nuclei positive index was
about 75%
TIA-1 Negative
CD2 Negative PAX5 Negative
CD3 Negative
Figure 2 1, 2 MR imaging of the head in 2011. The MRI T1Weighted Imaging shows that there is a irregular mass with equal T2 and a little bit
long T1 signals in the left frontal-parietal lobe, which is close to the outer edge of the meninges and a large finger-like edema around the mass
with the proof of the left lateral ventricle is pressed significantly and a 0.5 cm shift of the midline to the right side. (1) coronal plane; (2) sagittalia
plane. 3, 4 Hymatoxylin and eosin (H&E) shows the morphologic features of the neoplastic cells. The neoplastic cells are large, round or
oval, either diffused or sheet-spooty distributed, the cytoplasm is weak pink staining, some neoplastic cells like plasmatic cells with nuclei to one
side, and some nuclei looks like “clock face” shape. Some cells shows coarse chromatin with smaller or unapparent nucleoli, but some cells have
apparent nucleoli. The pathological mitosis and apoptosis are easy to find. (Magnification, ×400). 5–7 Immunohistochemistry staining shows
the expression of LCA, CD38, CD79a in the tumor tissues. Positive IHC signals are visualized with brown yellow color (5) There are diffused
LCA positive signals in the cytoplasm of a great number of neoplastic cells. (6) Extensive CD38 staining are detectable in numerous neoplastic
cells. (5) Some neoplastic cells are identified using CD79a IHC staining. (Magnification, ×200). 8 In situ hybridization shows EBV EBER
expression in the tumor tissues. Positive ISH signals are visualized with brown yellow color. There are significant positive siganals in most of
the neoplastic cells. (Magnification, ×200).
Zhang et al. Diagnostic Pathology 2012, 7:51 Page 3 of 5
http://www.diagnosticpathology.org/7/1/51specimen under the microscope. Immunohistochemstry
staining showed that the neoplastic cells were positive
for LCA (Figure 2 5), CD38 (Figure 2 6), CD79a (Figure 2
7), Plasma cell marker, Mum-1, kappa and lambda light
chains partly positive, CD20 weakly positive, and negative
for CD2, CD3, CD4, CD5, CD7, CD8, CD56, CD30,
CD138, ALK, TIA-1 and PAX5. Ki-67 positive index was
about 75% (all antibodies 1:100, Santa Cruz, Biotechnol-
ogy, Int., CA) (Table 1). EBER in situ hybridization on a
paraffin-embedded sections revealed the infection of
nearly all plasmablastic lymphoma cells by Epstein-Barr
virus (EBER probes, PanPath, Holand) (Figure 2 8). Gene
rearrangement assays followed the protocols of the
Biomed-2 PCR kit (InVivoScribe, CA), and the results
showed that IgH, IgK and IgL were positive, but TCRβ,
TCRδ and TCRγ were totally negative. (TCRβ [Vβ+ Jβ1/
2(−),Vβ+ Jβ2(−),Dβ+ Jβ1/2(−)]; TCRδ [Vδ+Dδ+ Jδ(-)];
TCRγ [Vγ1-8,Vγ10 +multiple Jγregions (−); Vγ9, Vγ11+
multiple Jγregions (−)]; IgH [VH-FR1 + JH Consensus
(+); VH-FR2 + JH Consensus (+); VH-FR3+ JH Consen-
sus (+); DH+ JH Consensus (−); DH7+ JH Consensus
(+)]; IgK [Vκ+ Jκ (−); Vκand intron +Kde (+)]; IgL [Vλ+
Jλ(+)].) (Figure 3).
Follow up data by regular visits to this patient, after
the operation, the patient was given anti-epileptictherapy, and started on chemotherapy with R-CHOP
(rituximab, cyclophosphamide, doxorubicin, leurocris-
time and prednisone) for one week. Two weeks later, the
symptoms of right limbs twitching were well controled,
hemiplegy of right limbs mainly disappeared. Then the
Figure 3 Gene arrangement assays of BCR (IgH, IgK, IgL) and TCR in the tumor tissues. Positive gene arrangements of BCR (IgH, IgK and
IgL) could be detected in the tumor tissues, but TCR β, δ and γ could not be. a. BCR (IgH, IgK, IgL) gene arrangement assays. Lane 1. IgH:
VH-FR1+ JH consensus (+); Lane 2, IgH: VH-FR2+ JH consensus (+); Lane 3, IgH: VH-FR3+ JH consensus (+); Lane 4, DH+ JH consensus (−); Lane 5,
DH7+ consensus (+); Lane 6, IgK: Vκ+ Jκ (−); Lane 7, IgK: Vκ and intron+ Kde (+); Lane 8, IgL: Vκ+ Jλ (+); Lane 9, Marker. b. TCR gene
arrangement assays. Lane 1, DNA ladder; Lane 2, TCRβ: Vβ+ Jβ1/2 (−); Lane 3, TCRβ: Vβ+ Jβ2 (−); Lane 4, TCRβ: Dβ+ Jβ1/2 (−); Lane 5, TCRδ:
Vδ+Dδ+ Jδ (−); Lane 6. TCRγ: Vγ1-8, Vγ10 +multiple Jγ regions (−); Lane 7, TCRγ: Vγ9, Vγ11 +multiple Jγ regions (−); Lane 8, Marker.
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tient to be alive eleven months after discharge.Conclusions
Plasmablastic lymphoma (PBL) is a rare, highly invasive
lymphoma, with diffuse proliferation of large neoplastic
cells most of which resemble B immunoblasts, some
tumor cells have immunophenotype of plasma cells. It
was a unique subtype of diffuse large B cell lymphoma.
It usually occures in HIV-positive individuals, predomin-
antly males. In recent years more researches show that
the pathogenesis of PBL has relationship with EBV and
HHV8 [3-5]. Tereza CC et al. revealed that the frontal
cortex is the main region to be frequently observed
neurological lesions after being infected by Bovine Her-
pesvirus type 5 (BoHV-5) comparing with parietal cor-
tex, thalamus and mesencephalon [6]. To the best of our
knowledge, this is the first case report for PBL occurence
in the intracranial frontal and parietal cortex region with
HIV negative but EBV positive, demonstrating the
occurance of this disease had relationship with the infec-
tion of EBV.
In this case immunophenotype showed that the neo-
plastic cells express a plasma cell phenotype including
CD38, positive for LCA, CD79a and Mum-1, high Ki67
proliferation index, extronodal localization, and the pres-
ence of EBV by in situ hybridization for EBER all sup-
ported the diagnosis of plasmablastic lymphoma.
In PBL clonal IgH chain and MYC gene rearrange-
ment is demonstrable, especially in those EBV-positive
patients, may show evidence of somatic hypermutation
or be in an unmutated configuration [7]. In this case the
plasmacytoid neoplastic cells occurred IgH gene re-
arrangement, both kappa and lambda light chains by
immunohistochemistry staining and gene rearrangementusing polymerase chain reaction method, it illustrated
that this case was a neoplastic lesions.
PBL should be morphologically distinguished with
anaplastic or plasmablastic plasma cell myeloma, immu-
noblastic cell type diffuse large B-cell lymphoma, ana-
plastic diffuse large B-cell lymphoma, ALK-positive large
B-cell lymphoma, primary effusion lymphoma and
HHV8-related origin of Castleman's disease, multi-cen-
ter B-cell lymphoma, and so on. It is easy to make the
correct diagnosis according to clinical history (immune
deficiency), disease site, tumor cell phenotype, high pro-
liferation index and EBER in situ hybridization, etc.
Owing to the PBL in this case occurred in the skull, it is
also need to be clinically and pathologically distinguished
with some other diseases such as central nervous system
metastases tumors, germ cell tumors, malignant melan-
oma, glioblastoma multiform and so on which also oc-
curring in the brain. Central nervous system metastases
usually oppear at the cerebrum and duramater places, es-
pecially the cinerea and white matter junction. CT scan
showing a clear boundary, equal density or low density
round lesions, with obvious peritumoral edema. MRI
showed low signal on T1WI, high signal in T2WI, obvi-
ous peritumoral edema, with enhanced signals when en-
hancement. The metastases tumors in the brain are
round or confluent, with clear border, gray or brown, and
other organs within the body is generally able to find the
primary tumor. The tumor cells can be distinguished
with PBL by morphology and immunophenotype. Germ
cell tumors are similar to PBL in morphology, which also
have round or oval large cells and prominent nucleoli,
with a background of small lymphocytes, but 90% of the
central nervous system germ cell tumors involving
patients under the age of 20, the peak age of 10–12 years
old. It commonly occures in the pineal gland, the
secondary place is saddle. The germ cell tumors
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can express PLAP and CD117, also express low molecu-
lar weight keratin, but do not express LCA, and plasma
cells markers. The tumor cells of malignant melanoma in
morphology could be alike with PBL, such as increased
nucleus and nucleolus, with deeply stained and coarse
chromatin, the mitosis and necrosis are easy to find.
Immunohistochemistry staining showed malignant mel-
anoma express S100, HMB-45 and Melan-A, but PBL
don’t express these markers. Glioblastoma multiform is a
rare glial tumors occur in children, adolescents and
young people, commonly sites are frontal lobe and par-
ietal lobe, the mass usually has clearly manifested bound-
aries Cell differentiation to obesity glioblastoma in
morphology also can be similar to PBL, the nucleus looks
like plasma cell-like, but can be found fence-like or polar
arrangement tumor cells around the hyperplastic blood
vessels and necrosis. The former express GFAP, S100 and
other neurogenic protein and glial markers to make a
confirm diagnosis.
About prognosis and predictive factors of PBL, the
clinical course is very aggressive. Most patients are stage
III or IV when they see a doctor. In addition, these dis-
ease is not sensitive to chemotherapeutics, and lack of
standard chemotherapy regimen. Most of the patients
dying in the first year after the diagnosis [8], primary
central nervous system lymphomas (PCNSL) coexsited
with HIV, the median srvival was 1.3 months [9].
Those not primary central neurous system PBL but
involved CNS, the median overall survival is about one
month [10].
This case report also emphasizes the importance of
clinical and radiological correlation in the diagnosis of
this lethal disease.Consent
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